Cargando…
HIF1α: A Novel Biomarker with Potential Prognostic and Immunotherapy in Pan-cancer
Cancer is a catastrophic disease that seriously affects human health. HIF1α plays an important role in cancer initiation, progression, and prognosis. However, little is known about the specific role of HIF1α in pan-cancer. Therefore, we systematically and comprehensively analyzed HIF1α using GEPIA,...
Autores principales: | Tian, Yonggang, Bai, Feihu, Zhang, Dekui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289759/ https://www.ncbi.nlm.nih.gov/pubmed/35860430 http://dx.doi.org/10.1155/2022/1246267 |
Ejemplares similares
-
N6AMT1 is a novel potential diagnostic, prognostic and immunotherapy response biomarker in pan-cancer
por: Wang, Mingqi, et al.
Publicado: (2023) -
Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets
por: Zhang, Yinqi, et al.
Publicado: (2021) -
YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021) -
Hypoxia inducible factor 1α gene (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer
por: Dales, Jean-Philippe, et al.
Publicado: (2010) -
An integrated pan-cancer analysis of PSAT1: A potential biomarker for survival and immunotherapy
por: Feng, Mingtao, et al.
Publicado: (2022)